[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334298-105":59,"doc-detail-334298-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-and-validation-of-kif20a-for-predicting-prognosis-and-treatment-outcomes-in-patients-with-breast-cancer","Identification and validation of KIF20A for predicting prognosis and treatment outcomes in patients with breast cancer","","KIF20A is investigated as a novel biomarker to predict breast cancer treatment response and disease progression. High-throughput sequencing of six breast cancer samples with paired normal tissues identified 1687 differentially expressed genes and highlighted KIF20A among key hub genes. Univariate and multivariate Cox analyses using METABRIC and GSE96058 support KIF20A as an independent predictor of overall survival. KIF20A aligns with cell-cycle activity and is enriched in fibroblasts and endothelial cells, where it co-expresses multidrug resistance genes. Database validation confirms that high KIF20A expression associates with improved treatment efficacy, suggesting clinical guidance for personalized therapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-and-validation-of-kif20a-for-predicting-prognosis-and-treatment-outcomes-in-patients-with-breast-cancer/334298/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-and-validation-of-kif20a-for-predicting-prognosis-and-treatment-outcomes-in-patients-with-breast-cancer/334298.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of the study on KIF20A?","Question",{"text":112,"@type":113},"To identify and validate KIF20A as a biomarker for predicting breast cancer prognosis and treatment outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was KIF20A linked to survival in patients?",{"text":117,"@type":113},"Univariate and multivariate Cox analyses on METABRIC and GSE96058 showed that KIF20A independently predicted overall survival.",{"name":119,"@type":110,"acceptedAnswer":120},"What cell-related and microenvironment patterns were associated with KIF20A?",{"text":121,"@type":113},"KIF20A correlated with cell-cycle phases and was enriched in fibroblasts and endothelial cells in the breast cancer stroma, where multidrug resistance genes were co-expressed.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334298,1791010366,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIdentification and validation of KIF20A for predicting prognosis and treatment outcomes in patients with breast cancer  \nMei Yang1,2,3, Hui Huang2,3, Yan Zhang1, Yiping Wang1, Junhao Zhao1, Peiyao Lee1, Yuhua Ma1􀀍 & Shaohua Qu1􀀍  \nBreast cancer is a leading cause of cancer-related deaths among women globally. It is imperative to explore novel biomarkers to predict breast cancer treatment response as well as progression. Here, we collected six breast cancer samples and paired normal tissues for high-throughput sequencing. By differential expression analysis, we found 1687 DEGs and identified the top 10 hub genes, including TOP2A, CDK1, BUB1B, KIF11, CCNA2, BUB1, CCNB1, KIF20A, DLGAP5 and CDC20 . Univariate and multivariate Cox analyses on the METABRIC database and GSE96058 dataset demonstrated that KIF20A was an independent prognostic predictor for overall survival. KIF20A was positively correlated with cell cycle phases, including the cell cycle process, cycle G2 M phase transition and cell cycle DNA replication initiation. Single-cell analyses revealed that KIF20A was enriched in fibroblasts and endothelial within breast cancer stroma. Meanwhile, multidrug resistance (MDR) genes ABCB1, ABCC1 and ABCG2 were co-expressed with KIF20A in fibroblasts and endothelial cells within the stroma.  \nMTABRIC database confirmed that high expression ofKIF20A was positively correlated with treatment efficacy in patients with breast cancer. In conclusion, KIF20A could be served as a predictive biomarker for breast cancer prognosis and treatment outcomes. KIF20A may play a significant role by regulating cell cycle progression and modulating stromal progression in breast cancer. Our findings provided novel molecular insights that can guide personalized treatment strategies in breast cancer.  \nKeywords breast cancer, KIF20A, tumor microenvironment, prognosis, treatment resistance  \nBreast cancer is the most common diagnosed cancer among women. In 2024, there will be 310,720 new cases of breast cancer in the United States, accounting for 32% of all female cancers, and 42,250 deaths from breast cancer, accounting for 15% of all cancer deaths1. Breast cancer has become a major burden of public health globally2. Although the combination of systematic treatment (chemotherapy, endocrine therapy and target therapy ) and local treatment (surgery and radiotherapy) were effective, treatment failure such as drug resistance still needs to be addressed3.  \nBreast cancer is a heterogeneous disease characterized by various gene mutations, genomic instabilities, and tumor microenvironment (TME)4. The tumor microenvironment consists of non-cancerous components within the tumor that produce and secrete molecules interacting with cancer cells, contributing to the initiation, progression, metastasis, and therapeutic resistance of cancer5–7. These hallmarks of breast cancer are closely related to different responses to different treatment strategies8. Current treatment strategies for breast cancer mainly depend on clinicopathological characteristics and molecular classification9, 10. However, even if patients with the same tumor grade and the same molecular subtype, treatment response may be different, leading to different clinical outcomes11, 12. Thus, the current breast tumor staging system and molecular classification system are no longer adequate to explain the heterogeneity of breast tumors. Novel molecular markers are urgently needed to better predict the heterogeneity and prognosis of breast cancer. The application of single-cell analysis techniques is conducive to precise diagnosis and treatment of breast cancer13, 14. Deep genetic analysis, such as next-generation sequencing (NGS) can provide new insights into breast cancer heterogeneity, which is widely used in diagnosis, treatment and prognosis prediction for breast cancer15, 16.  \n1Department of Breast Surgery, The First Affi","cbCaidLYv2jXOrUE","https://ap.wps.com/l/cbCaidLYv2jXOrUE","pdf",7765880,13,"English","# Materials and methods\n## Samples and datasets","[{\"question\":\"What was the main goal of the study on KIF20A?\",\"answer\":\"To identify and validate KIF20A as a biomarker for predicting breast cancer prognosis and treatment outcomes.\"},{\"question\":\"How was KIF20A linked to survival in patients?\",\"answer\":\"Univariate and multivariate Cox analyses on METABRIC and GSE96058 showed that KIF20A independently predicted overall survival.\"},{\"question\":\"What cell-related and microenvironment patterns were associated with KIF20A?\",\"answer\":\"KIF20A correlated with cell-cycle phases and was enriched in fibroblasts and endothelial cells in the breast cancer stroma, where multidrug resistance genes were co-expressed.\"}]","Identification and validation of KIF20A for predicting prognosis and treatment outcomes in patients with breast cancer | PDF",1790006181,33]